Letter: tofacitinib use for biologic-refractory paediatric inflammatory bowel disease.

Related Articles

Letter: tofacitinib use for biologic-refractory paediatric inflammatory bowel disease.

Aliment Pharmacol Ther. 2019 Oct;50(8):966-967

Authors: Dolinger MT, Rolfes P, Phan BL, Dubinsky MC

PMID: 31591772 [PubMed – in process]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/31591772?dopt=Abstract